| |
p <0.1 |
p <0.2 |
| HR |
p |
HR |
p |
| Overall Survival |
| Doses>60Gy |
2.53 |
0.06 |
2.2 |
0.13 |
| Previous surgery to 2nd radiation |
|
|
1.6 |
0.3 |
| Disease Free interval |
1.02 |
0.15 |
1.03 |
0.1 |
| Interval between treatments |
0.9 |
0.12 |
0.9 |
0.09 |
| Disease Free Survival |
| First treatment scheme |
1.14 |
0.56 |
1.05 |
0.82 |
| Doses >60Gy |
2.9 |
0.03 |
2.91 |
0.03 |
| Previous surgery to 2nd radiation |
|
|
1.44 |
0.44 |
| QT in the 2nd treatment |
|
|
0.94 |
0.92 |
| Second disease |
|
|
0.84 |
0.72 |
| Disease Free interval |
0.97 |
0.11 |
1.01 |
0.23 |
| Interval between treatments |
1.01 |
0.35 |
0.97 |
0.09 |
| Locoregional Control |
| Doses>60Gy |
3.12 |
0.04 |
3.2 |
0.03 |
| Previous surgery to 2nd radiation |
|
|
2.1 |
0.1 |
| QT in the 2nd treatment |
|
|
1.4 |
0.5 |
| Disease Free interval |
1.01 |
0.41 |
1.01 |
0.25 |
| Interval between treatments |
0.98 |
0.14 |
0.98 |
0.53 |
| Metastases Free Survival |
| Second disease |
|
|
0.2 |
0.02 |
| First Disease localization |
|
|
0.8 |
0.46 |
| First treatment scheme |
|
|
3.5 |
0.007 |
